181 related articles for article (PubMed ID: 18726921)
1. High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma.
Wang Z; Zhou JY; Kanakapalli D; Buck S; Wu GS; Ravindranath Y
Pediatr Blood Cancer; 2008 Dec; 51(6):754-9. PubMed ID: 18726921
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.
Wang Z; Xu J; Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 Sep; 66(17):8870-7. PubMed ID: 16951204
[TBL] [Abstract][Full Text] [Related]
3. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Cadalbert L; Sloss CM; Cameron P; Plevin R
Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
[TBL] [Abstract][Full Text] [Related]
4. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
Wang J; Zhou JY; Wu GS
Cancer Res; 2007 Dec; 67(24):11933-41. PubMed ID: 18089824
[TBL] [Abstract][Full Text] [Related]
5. Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells.
Qin W; Li S; Miao Y; Shi Q; Wang Y; Li J; Chen Z; Wang J; Ling C
Neoplasma; 2018; 65(1):21-33. PubMed ID: 29322785
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death.
Park J; Lee J; Kang W; Chang S; Shin EC; Choi C
Cell Death Dis; 2013 Feb; 4(2):e521. PubMed ID: 23449457
[TBL] [Abstract][Full Text] [Related]
7. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
Huang H; Wang L; Li M; Wang X; Zhang L
World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
[TBL] [Abstract][Full Text] [Related]
8. SIRT2 is involved in cisplatin-induced acute kidney injury through regulation of mitogen-activated protein kinase phosphatase-1.
Jung YJ; Park W; Kang KP; Kim W
Nephrol Dial Transplant; 2020 Jul; 35(7):1145-1156. PubMed ID: 32240312
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
11. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
12. STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression.
Liu R; Yang G; Bao M; Zhou Z; Mao X; Liu W; Jiang X; Zhu D; Ren X; Huang J; Chen C
Oncogene; 2022 Apr; 41(16):2265-2274. PubMed ID: 35236965
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.
Rincón R; Zazo S; Chamizo C; Manso R; González-Alonso P; Martín-Aparicio E; Cristóbal I; Cañadas C; Perona R; Lluch A; Eroles P; García-Foncillas J; Albanell J; Rovira A; Madoz-Gúrpide J; Rojo F
Mol Cancer Ther; 2016 Nov; 15(11):2780-2790. PubMed ID: 27599524
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
15. Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway.
Zhang L; Yang C; Huang Y; Huang H; Yuan X; Zhang P; Ye C; Wei M; Wang Y; Luo X; Luo J
Biomed Pharmacother; 2021 Feb; 134():111155. PubMed ID: 33370628
[TBL] [Abstract][Full Text] [Related]
16. Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.
Wang J; Zhou JY; Zhang L; Wu GS
Cell Cycle; 2009 Oct; 8(19):3191-8. PubMed ID: 19755862
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
19. MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance.
Wang J; Kho DH; Zhou JY; Davis RJ; Wu GS
Oncogene; 2017 Oct; 36(43):5939-5947. PubMed ID: 28650468
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
